Related Experiment Video
Updated: Aug 17, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Importance of HLA-DR matching in polytransfused cadaveric kidney transplant recipients. A prospective one-center
Insights
Human Leukocyte Antigen (HLA)-DR matching significantly improves kidney transplant survival, even in patients who received multiple blood transfusions. Better HLA-DR matching leads to higher graft survival rates and lower corticosteroid use.
Area of Science:
- Immunogenetics
- Transplantation immunology
- Nephrology
Background:
- Pre-transplant blood transfusions were standard for all recipients.
- Prospective Human Leukocyte Antigen (HLA)-DR typing was performed for donor-recipient pairs.
- Kidney allograft survival is influenced by genetic compatibility.
Purpose of the Study:
- To evaluate the impact of HLA-DR matching on cadaveric kidney allograft survival.
- To assess the effect of HLA-DR matching in polytransfused recipients.
- To determine the influence of HLA-DR matching on corticosteroid dosage.
Main Methods:
- Prospective HLA-DR typing in 157 donor-recipient pairs since August 1978.
- Analysis of graft survival rates based on the number of HLA-DR incompatibilities.
- Comparison of cumulative corticosteroid doses in the first year post-transplantation.
Main Results:
- One-year graft survival was 97% for recipients with no HLA-DR incompatibilities, 86% with one, and 73% with two.
- HLA-DR matching significantly improved graft survival, irrespective of prior transfusion history.
- Lower cumulative corticosteroid doses were observed in recipients with no HLA-DR incompatibilities.
- HLA-A and B matching did not show additional benefits for graft survival.
Conclusions:
- HLA-DR matching is a critical factor for successful cadaveric kidney transplantation.
- Optimizing HLA-DR compatibility can enhance long-term graft survival and reduce immunosuppression requirements.
- Focusing on HLA-DR matching offers significant clinical benefits in kidney transplantation outcomes.
Abstract:
Since August 1978 prospective HLA-DR typing has been performed in 157 donor-recipient pairs. All recipients received pretransplant blood transfusions. This study shows that HLA-DR matching can significantly improve the survival of cadaveric kidney allografts, even in polytransfused recipients. Patients receiving kidneys with no HLA-DR incompatibilities have a one-year graft survival of 97%, versus 86% for recipients with 1 HLA-DR incompatibility and 73% for recipients with 2 HLA-DR incompatibilities. The cumulative dose of corticosteroids during the first year after transplantation is significantly lower in patients with no DR-incompatibilities. HLA-A and B matching have no additional effect on graft survival.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure

